IceCure Medical (ICCM) Accumulated Depreciation & Amortization (2020 - 2025)

IceCure Medical has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $1.8 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 16.7% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 16.7%, while the annual FY2025 figure was $1.8 million, 16.7% up from the prior year.
  • Accumulated Depreciation & Amortization was $1.8 million for Q4 2025 at IceCure Medical, up from $1.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.8 million in Q4 2025 and bottomed at $127000.0 in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $1.2 million (2023), against an average of $991000.0.
  • Year-over-year, Accumulated Depreciation & Amortization surged 391.53% in 2023 and then increased 16.7% in 2025.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $127000.0 in 2021, then surged by 95.28% to $248000.0 in 2022, then surged by 391.53% to $1.2 million in 2023, then increased by 27.24% to $1.6 million in 2024, then increased by 16.7% to $1.8 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $1.8 million (Q4 2025), $1.6 million (Q4 2024), and $1.2 million (Q4 2023) per Business Quant data.